Decision Aid Pamphlet for People with Low-Risk Thyroid Cancer
Tests a printed decision aid in adults newly diagnosed with low-risk thyroid cancer.
Plain-language title generated from the registry record
Registry title: Decision Aid Efficacy in Low Risk Thyroid Cancer
Key facts
- Where
- Baltimore, United StatesSee the site
Where in United States
- University of Maryland, BaltimoreBaltimore, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Maryland, Baltimore
- Trial code
- NCT07536412
- Record updated
- 17 April 2026
- Original description
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.Read full original descriptionShow less
Efficacy of a Patient-facing Decision Aid in Reducing Decision Anxiety and Improving Decision Readiness in Low Risk Thyroid Cancer
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.
Inclusion: Low-risk thyroid cancer or thyroid nodule suspicious for malignancy; English-speaking.
Exclusion: Prior consultation with surgeon regarding the thyroid nodule / cancer in question; Cancer/nodule has high risk features (e.g. extrathyroidal extension on ultrasound); History of thyroid cancer; History of thyroid surgery; Currently pregnant (per patient report).